Non-Human Primate (NHP) Plasma Protein Binding (PPB) Assay Service

Accurate Prediction for Safe and Effective Therapeutics. Are you currently facing long drug development cycles, difficulty in predicting human PK profiles, and challenges in accurately translating preclinical data to human trials? Our Non-Human Primate PPB In Vitro DMPK Assays help you accelerate drug discovery by providing high-quality, translatable data through our advanced in vitro screening platforms and gold-standard methodologies.

Overview of NHP PPB Assays

Plasma protein binding (PPB) is a vital factor in drug development, signifying the reversible binding of a compound to blood plasma proteins, including albumin and α-1-acid glycoprotein. Only the "free" or unbound drug fraction remains pharmacologically effective, reaching its target and undergoing metabolism or elimination. Understanding PPB is crucial for predicting drug efficacy and safety. Our Non-Human Primate (NHP) Plasma Protein Binding In Vitro DMPK Assays provide a specialized service to measure how extensively a drug candidate binds to plasma proteins in NHPs. This is critical in preclinical drug development, particularly for biologics like monoclonal antibodies, where NHPs are a key model.

What Our Service Is

Our services are specifically designed for:

• Dose Translation: Guiding the selection of preclinical doses that can be safely and effectively translated into human clinical trials.
• Safety Prediction: Identifying potential toxicity risks by assessing the unbound drug concentration, which is responsible for therapeutic and adverse effects.
• Interspecies Extrapolation: Providing translatable data to predict human pharmacokinetics (PK) with higher confidence, reducing the risk of failure in later-stage clinical development.

Why Choose Us?

The challenges of accurately translating preclinical data often result in costly project delays and setbacks. At Creative Biolabs, we transform these pain points into tangible benefits by providing high-quality, reliable data that de-risks your drug development pipeline. Our commitment to scientific excellence ensures that you receive the most accurate and actionable PPB data available.

• The difficulty of translating PK data from rodents to humans-We leverage NHP models, which have a genetic and immunological similarity to humans, providing a superior foundation for predicting human PK and PD.
• The lack of standardized, reproducible data from in-house or non-specialized labs-Our assays are performed using gold-standard methodologies like Equilibrium Dialysis, with rigorous quality control to ensure reproducible and reliable results every time.

Fig.1 Association of pharmaceutical compounds with the plasma protein albumin.¹

Key Benefits of Our Service

At Creative Biolabs, our commitment to speed, precision, and comprehensive service sets us apart. We provide a competitive advantage that can significantly accelerate your project timelines and improve your chances of success.

• Exceptional Response Speed: Our streamlined processes and dedicated team ensure rapid turnaround times without compromising data quality.
• Comprehensive NHP Resources: We ensure assay consistency and reliability by maintaining a steady and reliable supply of premium NHP plasma.
• Customization and Flexibility: Our assays can be tailored to meet the unique needs of your compound, addressing challenges such as low solubility or high non-specific binding.
• Comprehensive Reporting: You receive a detailed, in-depth report that goes beyond raw numbers, including full data analysis, method summaries, and expert interpretations.

How Creative Biolabs' Assays Can Assist Your Project?

Our service is designed to be a seamless, end-to-end solution that provides you with the critical data you need to advance your therapeutic candidate with confidence. Our process is clear, transparent, and focused on delivering actionable insights.

Workflow

Key Deliverables

Our service provides you with a complete and compliant data package to support your drug development and regulatory submissions:

• A detailed lab report that encompasses the materials, methods, findings, and conclusions.
• Raw data files from LC-MS/MS analysis.
• A succinct overview of principal findings and their significance.
• Model annotations and other relevant data files for PK/PD modeling.
• A certificate of analysis for the raw materials used.

Capabilities & Partnerships

Service-Specific Data

• Annual Sample Size: Over 50,000 compounds
• Typical Turnaround Time (TAT): 10-15 business days
• Assay Pass Rate: >98%

Our Valued Partners

Frequently Asked Questions

Contact Us

At Creative Biolabs, we are dedicated to providing the highest-quality preclinical data to accelerate your journey from discovery to clinical success. Our Non-Human Primate PPB In Vitro DMPK Assays are a testament to our scientific expertise, technological capabilities, and commitment to client satisfaction. To discuss how our NHP PPB services can provide the data you need to advance your project, please reach out to our team of experts.